MeSH term | MeSH ID | Detail |
---|---|---|
Mitochondrial Diseases | D028361 | 25 associated lipids |
Insulin Resistance | D007333 | 99 associated lipids |
Coronary Disease | D003327 | 70 associated lipids |
Total
3
Palmitoylcarnitine is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with Palmitoylcarnitine
MeSH term | MeSH ID | Detail |
---|---|---|
Mitochondrial Diseases | D028361 | 25 associated lipids |
Insulin Resistance | D007333 | 99 associated lipids |
Coronary Disease | D003327 | 70 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Shi X et al. | Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity. | 2012 | J. Lipid Res. | pmid:22904346 |
Jørgensen W et al. | Progression of type 2 diabetes in GK rats affects muscle and liver mitochondria differently: pronounced reduction of complex II flux is observed in liver only. | 2012 | Am. J. Physiol. Endocrinol. Metab. | pmid:22713504 |
Tonazzi A et al. | Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups. | 2012 | Biochim. Biophys. Acta | pmid:22365929 |
Wenderska IB et al. | Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development. | 2011 | Chembiochem | pmid:22045628 |
Brandhonneur N et al. | Ex vivo and in vivo diffusion of ropivacaine through spinal meninges: influence of absorption enhancers. | 2011 | Int J Pharm | pmid:21056096 |
Doi N et al. | Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers. | 2011 | Drug Metab. Pharmacokinet. | pmid:21206134 |
De Jesús VR et al. | Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. | 2010 | Clin. Chim. Acta | pmid:20122909 |
Hoffman DL and Brookes PS | Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. | 2009 | J. Biol. Chem. | pmid:19366681 |
Wu Y et al. | The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction. | 2009 | J. Pharmacol. Exp. Ther. | pmid:19403851 |
Bonnefont JP et al. | Bezafibrate for an inborn mitochondrial beta-oxidation defect. | 2009 | N. Engl. J. Med. | pmid:19228633 |